Logo image of QPT.CA

QUEST PHARMATECH INC (QPT.CA) Stock Fundamental Analysis

TSX-V:QPT - TSX Venture Exchange - CA74836M1068 - Common Stock - Currency: CAD

0.035  -0.01 (-22.22%)

Fundamental Rating

2

QPT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 22 industry peers in the Biotechnology industry. QPT has a bad profitability rating. Also its financial health evaluation is rather negative. QPT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

QPT had positive earnings in the past year.
QPT had a negative operating cash flow in the past year.
QPT had negative earnings in 4 of the past 5 years.
QPT had a negative operating cash flow in each of the past 5 years.
QPT.CA Yearly Net Income VS EBIT VS OCF VS FCFQPT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With an excellent Return On Assets value of 59.39%, QPT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Equity of QPT (62.17%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 59.39%
ROE 62.17%
ROIC N/A
ROA(3y)-115.95%
ROA(5y)-75.7%
ROE(3y)-119.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QPT.CA Yearly ROA, ROE, ROICQPT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for QPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QPT.CA Yearly Profit, Operating, Gross MarginsQPT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, QPT has about the same amount of shares outstanding.
The number of shares outstanding for QPT has been increased compared to 5 years ago.
Compared to 1 year ago, QPT has a worse debt to assets ratio.
QPT.CA Yearly Shares OutstandingQPT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
QPT.CA Yearly Total Debt VS Total AssetsQPT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

QPT has an Altman-Z score of 2.02. This is not the best score and indicates that QPT is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.02, QPT belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that QPT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.04, QPT is doing good in the industry, outperforming 77.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 2.02
ROIC/WACCN/A
WACCN/A
QPT.CA Yearly LT Debt VS Equity VS FCFQPT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

QPT has a Current Ratio of 0.31. This is a bad value and indicates that QPT is not financially healthy enough and could expect problems in meeting its short term obligations.
QPT has a worse Current ratio (0.31) than 68.18% of its industry peers.
QPT has a Quick Ratio of 0.31. This is a bad value and indicates that QPT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.31, QPT is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
QPT.CA Yearly Current Assets VS Current LiabilitesQPT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 231.78% over the past year.
EPS 1Y (TTM)231.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QPT.CA Yearly Revenue VS EstimatesQPT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 500K 1M 1.5M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.39, the valuation of QPT can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of QPT indicates a rather cheap valuation: QPT is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 24.21. QPT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.39
Fwd PE N/A
QPT.CA Price Earnings VS Forward Price EarningsQPT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QPT.CA Per share dataQPT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

QPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUEST PHARMATECH INC

TSX-V:QPT (5/9/2025, 7:00:00 PM)

0.035

-0.01 (-22.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)12-19 2024-12-19
Earnings (Next)05-28 2025-05-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.27%
Ins Owner ChangeN/A
Market Cap5.92M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.39
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB 0.26
EV/EBITDA N/A
EPS(TTM)0.09
EY257.14%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 59.39%
ROE 62.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-115.95%
ROA(5y)-75.7%
ROE(3y)-119.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z 2.02
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)231.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.87%
OCF growth 3YN/A
OCF growth 5YN/A